Your session is about to expire
← Back to Search
Psychotherapy
Psychotherapy for Postpartum Depression
N/A
Recruiting
Led By Nili Solomonov, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Mini Mental Status Exam (MMSE) ≤ 1 SD below the mean score for patient's age and education
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a remote therapy called Engage & Connect for new mothers with postpartum depression. The therapy aims to reduce depression by encouraging social activities with significant others, helping mothers feel happier and less isolated.
Who is the study for?
This trial is for new mothers 4-12 weeks post-delivery who are experiencing postpartum depression, as indicated by a score of ≥10 on the Edinburgh Postnatal Depression Scale. Participants should be either off antidepressants or on a stable dose for at least 8 weeks and speak English well. Those with severe psychiatric conditions other than certain anxiety disorders or specific phobias, using certain psychotropic drugs, or undergoing ongoing psychotherapy are excluded.
What is being tested?
The study is testing 'Engage & Connect,' a new type of psychotherapy designed to help reduce postpartum depression. It involves 9 weeks of remote therapy sessions aimed at decreasing feelings of social isolation and improving how social rewards are processed, along with measuring changes in the severity of depression.
What are the potential side effects?
Since this trial involves psychotherapy rather than medication, traditional side effects associated with drugs may not apply. However, participants might experience emotional discomfort discussing personal issues during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My mental function test score is slightly below average for my age and education.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Depression, Postpartum
Secondary study objectives
Mental Depression
Change in Social Reward Processing on STAR task
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Engage & ConnectExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,138,839 Total Patients Enrolled
3 Trials studying Postpartum Depression
732 Patients Enrolled for Postpartum Depression
Nili Solomonov, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
188 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You scored 10 or higher on the Edinburgh Postnatal Depression Scale (EPDS).I am able to understand and agree to the research and treatment plan.I use no more than 0.5 mg of lorazepam daily or less.You have a history of mental health conditions other than major depression, generalized anxiety, persistent depression, or specific phobias.I am currently in psychotherapy, but not more than once every 8 weeks.My mental function test score is slightly below average for my age and education.I have been on a stable dose of antidepressants for 8 weeks and don't plan to change it.If you were pregnant before and had a baby with serious health problems or if the baby was stillborn or died soon after birth, you cannot participate.
Research Study Groups:
This trial has the following groups:- Group 1: Engage & Connect
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger